Home / People / Dr. Jacob Siebert
Jacob Siebert

Dr. Jacob Siebert


CMS Hasche Sigle
Stadthausbrücke 1-3
20355 Hamburg
CMS Hasche Sigle
Nymphenburger Straße 12
80335 Munich
Languages English, German

Jacob Siebert advises strategic investors and private equity funds on mostly cross-border M&A transactions, joint ventures and private equity investments. He is an expert for leveraged buyouts and public takeovers and also provides ongoing corporate law advice to his clients. Jacob has special sector expertise in life sciences and consumer goods.

Jacob joined CMS in 2003 and was made partner in 2012. In 2009/2010, he spent six months on secondment with investment funds in London.

more less

Relevant experience

  • Advising BC Partners on their Aenova Group investment and on subsequent transactions
  • Advising Almirall on selling its respiratory tract diseases division to Astra-Zeneca
  • Advising Mayfair on the merger of Germanische Llloyd and Det Norske Veritas
  • Advising Groupe CAT on acquiring Wallenius Wilhelmsen Logistics Germany
  • Advising Capiton and SüdBG on selling svt Brandschutz
more less


  • 2005: PhD at the University of Bonn
  • 2002: Second state examination in law
  • 2000 - 2002: trainee lawyer at Higher Regional Court Stuttgart
  • 1999: First state examination in law in Düsseldorf
  • Law studies at the University of Bonn
  • 1992 - 1994: Trained as a banker in Stuttgart
more less


  • SPACs - an attractive acquisition model for the German market - first experiences from legal point of view, Corporate Finance law 2010, p. 224 ff
  • SPAC - A new asset class in Europe, Corporate Finance law 2010, p. 13 ff
  • Debt-Equity-Swap-Transactions, Finance Magazin-Sonderbeilage 2009, p. 18
  • "The Liability of Members of the Take-Over Consortium under the Rules of Concealed Contribution in Kind", Neue Zeitschrift für Gesellschaftsrecht 2006, p. 366 ff
  • One-Man-Partnerships, 2005
more less


Show only
CMS ad­vises share­hold­ers on sale of WOW Tech Group...
Private equity pan­el 2019/II sur­vey by CMS and Fin­ance:...
CMS ad­vises AFIN­UM on sched­uled sale of minor­ity stake...
CMS ad­vises pro­duc­tion com­pany i&u TV on ac­quis­i­tion...
Private equity pan­el 2019/I sur­vey by CMS and FIN­ANCE:...
CMS ad­vises crude oil and nat­ur­al gas group DEA on...
CMS ad­vises AFIN­UM on in­vest­ment in LED torch and head...
Private equity pan­el 2018/III sur­vey by CMS and FIN­ANCE:...
AFIN­UM ad­vised by CMS on in­vest­ment in or­gan­ic food...
Private equity pan­el 2018/II sur­vey by CMS and FIN­ANCE:...
Private Equity Pan­el 2018/I von CMS und FIN­ANCE: Die...
CMS and Schjødt ad­vise May­fair on sale of shares in...